{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-21-000059","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2021-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.615816+00:00","generated_at":"2026-06-29T18:10:57.806727+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Penumbra Q2 revenue $184.3M (+75.3% YoY); raises FY2021 guidance to $720-730M","bullets":["Revenue $184.3M (+75.3% YoY); vascular $100.7M (+117.6%), neuro $83.6M (+42.0%).","Operating income of $10.3M vs. operating loss of $17.6M in Q2 2020.","Gross margin improved to 64.4% from 61.8%.","Full-year 2021 revenue guidance raised to $720-730M from $695-705M (28-30% growth).","No EPS figure provided in release."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-21-000059","json":"https://secwatch.observer/filing/0001321732-21-000059.json","markdown":"https://secwatch.observer/filing/0001321732-21-000059.md","text":"https://secwatch.observer/filing/0001321732-21-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173221000059/0001321732-21-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173221000059/pen-20210809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T18:10:57.806727+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}